TNF and rheumatoid arthritis: However, several large epidemiological studies found no increased risk in overall malignancy or solid malignancy associated with anti-tumour necrosis factor (TNF) use compared with non-use or methotrexate.24, 26, 31, 38 The majority of studies examining the effect of medication use on malignancy in RA have focused on lymphoma.